Albumin Dialysis in Critically Ill Patients: Use Versus Omission of Intradialytic Heparin
- 8 May 2008
- journal article
- Published by Wiley in Artificial Organs
- Vol. 32 (5), 411-416
- https://doi.org/10.1111/j.1525-1594.2008.00560.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Anticoagulation Minimization Is Safe and Effective in Albumin Liver Dialysis Using the Molecular Adsorbent Recirculating SystemArtificial Organs, 2007
- Review Article: Clinical Experience With PrometheusTherapeutic Apheresis and Dialysis, 2006
- THIS ARTICLE HAS BEEN RETRACTED: An Australian Experience With the Molecular Adsorbents Recirculating System (MARS)Therapeutic Apheresis and Dialysis, 2006
- Fulminant hepatic failureCurrent Treatment Options in Gastroenterology, 2005
- The Decrease in Cytokine Concentration During Albumin Dialysis Correlates With the Prognosis of Patients With Acute on Chronic Liver FailureTransplantation Proceedings, 2005
- Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysisLiver Transplantation, 2004
- Characterization of treatment dose delivered by albumin dialysis in the treatment of acute renal failure associated with severe hepatic dysfunctionClinical Nephrology, 2002
- Albumin dialysis and Molecular Adsorbents Recirculating System (MARS) for acute Wilson's diseaseLiver Transplantation, 2002
- Molecular Adsorbent Recycling System (MARS): Clinical Results of a New Membrane‐Based Blood Purification System for Bioartificial Liver SupportArtificial Organs, 1999
- Comparison of the Use of Standard Heparin and Prostacyclin Anticoagulation in Spontaneous and Pump-Driven Extracorporeal Circuits in Patients with Combined Acute Renal and Hepatic FailureNephron, 1994